Takeda Pharmaceutical Company Ltd
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA
- Conditions
- Crohn's DiseaseUlcerative Colitis
- First Posted Date
- 2025-03-04
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Takeda
- Registration Number
- NCT06856135
- Locations
- 🇺🇸
Children's Center for Digestive Healthcare, Atlanta, Georgia, United States
🇺🇸University of California San Francisco, San Francisco, California, United States
🇺🇸Seattle Children's Hospital, Seattle, Washington, United States
A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
- Conditions
- Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 124
- Registration Number
- NCT06831370
- Locations
- 🇮🇳
HCG City Cancer Centre, Vijayawada, Andhra Pradesh, India
🇮🇳Gauhati Medical college and Hospital, Guwahati, Assam, India
🇮🇳Unique Hospital Multispeciality and Research Institute, Surat, Gujarat, India
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Takeda
- Target Recruit Count
- 40
- Registration Number
- NCT06812078
- Locations
- 🇺🇸
Takeda Site 27, Colorado Springs, Colorado, United States
🇺🇸Takeda Site 29, Saint Louis, Missouri, United States
🇺🇸Takeda Site 28, Norfolk, Virginia, United States
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Conditions
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Interventions
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Takeda
- Target Recruit Count
- 36
- Registration Number
- NCT06798012
- Locations
- 🇺🇸
Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Takeda
- Target Recruit Count
- 78
- Registration Number
- NCT06793943
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS)
- First Posted Date
- 2025-01-10
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Takeda
- Target Recruit Count
- 1
- Registration Number
- NCT06768658
- Locations
- 🇺🇸
New Phase Research & Development, Knoxville, Tennessee, United States
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Takeda
- Target Recruit Count
- 183
- Registration Number
- NCT06764615
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Conditions
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Interventions
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 59
- Registration Number
- NCT06747351
A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan
- Conditions
- Dengue Fever
- Interventions
- Biological: TDVOther: Placebo
- First Posted Date
- 2024-12-19
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Takeda
- Target Recruit Count
- 187
- Registration Number
- NCT06741683
- Locations
- 🇯🇵
Saitama City Hospital, Saitama-shi, Saitama, Japan
🇯🇵Sumida Hospital, Sumida-ku, Tokyo, Japan
🇯🇵OKURA Otolaryngology Clinic, Toshima-ku, Tokyo, Japan
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Conditions
- Immune Thrombocytopenic Purpura (ITP)
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Takeda
- Target Recruit Count
- 171
- Registration Number
- NCT06722235
- Locations
- 🇨🇳
The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
🇨🇳Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hebei, China
🇨🇳The First Affiliated Hospital of Nanchang University - Donghu Campus, Nanchang, Jiangxi, China